Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Brian Slingerland"'
Autor:
Piotr Czapiewski, Wade C. Anderson, Sheila Bheddah, KristenAnn Black, William D. Travis, Brian Slingerland, Orit Foord, Paul Anthony Escarpe, John T. Poirier, Marybeth A. Pysz, Amy Laysang, Afshin Dowlati, Jacek Jassem, Scott J. Dylla, Howard Philip Wilson, Desai Radhika Chetan, Alexander J. Bankovich, Javier Lopez-Molina, Andrzej Badzio, Hui Shao, David R. Liu, Torgov Michael, David H. Harpole, Johannes Hampl, Robert A. Stull, Samuel A. Williams, Pierre P. Massion, Charles M. Rudin, Laura Saunders, M. Catherine Pietanza, Monette Aujay, Albert Park, Milly Milton
Publikováno v:
Science translational medicine. 7(302)
The high-grade pulmonary neuroendocrine tumors, small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC), remain among the most deadly malignancies. Therapies that effectively target and kill tumor-initiating cells (TICs) in thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab6ac90e9ee792cd39eb17907cb8113
https://pubmed.ncbi.nlm.nih.gov/28361078
https://pubmed.ncbi.nlm.nih.gov/28361078
Autor:
Wade C. Anderson, Jorge Aguilar, Amy Laysang, Michael Boyd, Sheila Bheddah, Edmundo Rubio, Johanna Ramoth, Scott J. Dylla, Brian Slingerland, Brett Pickell, Marybeth A. Pysz
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125255 (2015)
PLoS ONE
PLoS ONE
Small cell lung cancer (SCLC) is a devastating disease with limited treatment options. Due to its early metastatic nature and rapid growth, surgical resection is rare. Standard of care treatment regimens remain largely unchanged since the 1980’s, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::624cd5901c96bf748265ea9e66b1782b
http://europepmc.org/articles/PMC4425530?pdf=render
http://europepmc.org/articles/PMC4425530?pdf=render